Welcome to our dedicated page for Retractable Tech SEC filings (Ticker: RVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Retractable Technologies, Inc. (RVP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Retractable’s filings, including Form 10-K annual reports, Form 10-Q quarterly reports, and Form 8-K current reports, describe its business of manufacturing and marketing VanishPoint®, EasyPoint®, and Patient Safe® safety medical products, as well as key financial and operational details.
In its periodic reports, Retractable discusses net sales, operating income or loss, domestic and international revenue mix, and the influence of product mix between VanishPoint® syringes and EasyPoint® needles on average selling prices and margins. The filings also address the material impact of tariffs on needles, syringes, and other products imported from China, and explain how these costs are reflected in cost of manufactured product. Disclosures describe the company’s efforts to increase U.S.-based manufacturing, adapt equipment for domestic production, and adjust its workforce in response to tariff pressures.
Form 8-K current reports for RVP document material events such as quarterly and annual results announcements, preferred stock dividend declarations for Series II Class B and Series III Class B Convertible Preferred Stock, workforce reductions, and product-related recognitions. These filings confirm that Retractable’s common stock is registered on NYSE American under the symbol RVP and that the company is incorporated in Texas.
On Stock Titan, users can review these SEC filings with AI-powered summaries that highlight key points from lengthy documents, such as discussions of tariffs, product mix, liquidity considerations, and risk factors related to patent protection, supplier relationships, foreign trade risk, access to markets, production costs, and competition from larger safety device providers. The platform also surfaces updates in near real time as new filings are posted to EDGAR, helping users quickly see changes in Retractable’s reported results, capital structure, or material events.
By combining the full text of RVP’s SEC filings with AI-generated explanations, this page is intended to make it easier to understand how Retractable’s safety medical device business, financial performance, and risk disclosures are presented in its official regulatory documents.
Retractable Technologies (RVP) reported an insider transaction by President and CEO Thomas J. Shaw, who is also a director and 10% owner. On 10/28/2025, he purchased 35,000 shares of common stock at a weighted average price of $0.9151 (transaction code P).
Following this trade, Mr. Shaw beneficially owns 15,802,891 shares directly and 831,600 shares indirectly with “Voting or Investment Control.” The filing notes he has investment power over 500,000 shares as Trustee for a family member and voting control over the remainder pursuant to a voting agreement. A Rule 10b5‑1 plan was adopted on August 22, 2024.
Retractable Technologies (RVP) President and CEO (also Director and 10% Owner) reported a purchase of 34,506 shares of common stock on 10/27/2025 at a weighted average price of $0.9425 (Transaction Code: P).
Following the transaction, beneficial ownership stands at 15,767,891 shares held directly and 831,600 shares held indirectly. The filing notes a Rule 10b5-1 plan adopted on August 22, 2024. Indirect holdings include 500,000 shares over which the insider has investment power as Trustee for a family member, and voting control over the remainder pursuant to a voting agreement.
Retractable Technologies (RVP) reported an insider purchase by Mr. Shaw, its President and CEO, Director, and 10% Owner. On 10/23/2025, he bought 356 shares of common stock at a weighted average price of $0.951, made pursuant to a Rule 10b5-1(c) trading plan adopted on August 22, 2024.
Following the transaction, Mr. Shaw beneficially owns 15,733,385 shares directly and 831,600 shares indirectly. The indirect holdings include 500,000 shares over which he has investment power as trustee for a family member, and he has voting control over the remainder pursuant to a voting agreement.
Retractable Technologies (RVP) reported an insider purchase by its President, CEO, Director, and 10% owner, Mr. Shaw. On 10/22/2025, he acquired 10,000 shares of common stock at a weighted average price of $0.96 (Form 4, code P).
Following the transaction, he beneficially owns 15,733,029 shares directly and 831,600 shares indirectly. As noted, he has investment power over 500,000 shares as trustee for a family member and voting control over the remainder pursuant to a voting agreement. A Rule 10b5-1 plan was noted with an adoption date of August 22, 2024.
Retractable Technologies (RVP): Mr. Shaw (Director, President and CEO, and 10% Owner) reported a purchase of 14,204 shares of common stock on 10/14/2025 at a weighted average price of $0.9256 (transaction code P).
Following the transaction, he beneficially owns 15,723,029 shares directly and 831,600 shares indirectly. The indirect holdings include 500,000 shares over which he has investment power as Trustee for a family member and the remainder subject to a voting agreement. A Rule 10b5-1 plan was adopted on August 22, 2024.
Retractable Technologies, Inc. reporting person Thomas J. Shaw (President, CEO, Director and >10% owner) acquired 30,000 shares of common stock on 10/08/2025 at a weighted average price of $0.9233. After the purchase Mr. Shaw beneficially owns 15,708,825 shares directly and has an indirect beneficial interest in 831,600 shares as Trustee for a family member; voting control over the remainder is held via a voting agreement. The transaction was executed under a Rule 10b5-1 trading plan adopted on Aug 22, 2024. The Form 4 was signed by an attorney-in-fact on 10/09/2025.
Retractable Technologies, Inc. filed a Form 8-K to report that it has declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The company disclosed this action through a press release that is attached as Exhibit 99 to the report, ensuring these preferred shareholders are informed about the new dividend.
The filing is limited to announcing this dividend declaration and does not include common stock dividend details, financial results, or other operational updates.
Thomas J. Shaw, President and CEO of Retractable Technologies, acquired 5,000 shares of the company's common stock on 09/29/2025 at a weighted average price of $0.8201 under a Rule 10b5-1 plan adopted 08/22/2024. After the transaction, Mr. Shaw directly beneficially owns 15,678,825 shares and indirectly holds 831,600 shares for which he has voting or investment control as Trustee for a family member. The filing was signed by an attorney-in-fact on 09/30/2025.
Thomas J. Shaw, President & CEO, director and 10% owner of Retractable Technologies, reported a purchase of 17,500 shares of the company on 09/24/2025 at a weighted-average price of $0.802 under a Rule 10b5-1 plan adopted on 08/22/2024. After the transaction he beneficially owns 15,673,825 shares directly and 831,600 shares indirectly.
The filing notes Mr. Shaw holds investment power over 500,000 shares as trustee for a family member and retains voting control over the remaining indirectly held shares pursuant to a voting agreement. The Form 4 was signed by an attorney-in-fact on 09/25/2025.
Thomas J. Shaw, President, CEO and >10% owner of Retractable Technologies, Inc. (RVP), reported an insider purchase under a Rule 10b5-1 plan. On 09/23/2025 Mr. Shaw purchased 2,500 shares of RVP common stock at a weighted-average price of $0.815 per share. After the transaction he directly beneficially owned 15,656,325 shares and indirectly owned 831,600 shares (the indirect holdings include >500,000 shares held in trust for a family member where he has investment power and voting control over the remainder via a voting agreement). The Form 4 was signed by an attorney-in-fact on 09/24/2025 and notes the 10b5-1 plan adoption date of August 22, 2024.